Remove 2004 Remove Competition Remove Food
article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Pharma 64
article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. In addition, he was Head of the Legal Service at the European Medicines Agency from 2004 to 2012.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interchangeability of biosimilars in the EU – the industry impact

European Pharmaceutical Review

Marie advises clients in the pharmaceutical, biotechnology, medical devices, chemicals, cosmetics and food sectors in proceedings before both national and European courts and the regulatory agencies in the UK and across Europe. The Impact of Biosimilar Competition in Europe, IQVIA, December 2021. Directive 2001/83 (as amended).

article thumbnail

Reality Bites: Disappointment in the R&D Sector

Pharmaceutical Technology

This is confirmed by the Centre for Medicines Research International which shows in 2004 that more than 20% of the money invested in R&D by ten of the largest pharmaceutical companies went on line extensions, as opposed to new development projects. %, while R&D accounts for just 17.1%

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 13 Currently, over 350 herbal remedies have been granted a THR licence. 2012/1916).

Marketing 103
article thumbnail

Uri Goren

Cadensee

When he was going through his cancer, he died in 2004. They brought food for vaccine; people vaccinated for a piece of food. I don't know about food, but here it was beer. And there I now started to post only food. Like, I just do some what we call food porn on Instagram. We're very simple creatures.

article thumbnail

API nitrosamines: method sensitivity issues

European Pharmaceutical Review

1 This has led to a great deal of pre-competitive data sharing. As the data is anonymised it will not be possible to select excipient suppliers based on lowest available nitrite levels, but it may prompt some suppliers to publish this information as it could provide a competitive advantage. Food and Drug Administration.